RCT | Oncological outcome of short-term, intensive chemoresection with mitomycin in nonmuscle invasive bladder cancer.

DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Chemoresection Reduces Need for Surgery in Nonmuscle Invasive Bladder Cancer – Cancer Therapy Advisor

Commentary on Twitter

✅ DaBlaCa-13: Oncological outcome of short-term, intensive chemoresection with mitomycin C in non muscle invasive #BladderCancer ? https://t.co/G7jmPNyaao #JCO #blcsm @SkydtLindgren @JBjerggaard @LDyrskjot @NessnAzawi pic.twitter.com/KHn4gOHtnv

— Journal of Clinical Oncology (@JCO_ASCO) October 28, 2022